← Leaderboards
Mark Chalfant Walker
University Of Illinois At Urbana-Champaign
$1,878,445
Attributed
$1,878,445
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $343.6K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,878,445 · 2
By mechanism
R35$1,714,719 · 1
F32$163,726 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Urbana-Champaign
Same institution · by research overlap
- Douglas Alan Mitchell$12,458,055
- Satish K Nair$11,705,771
- Elizabeth Ivy Parkinson$2,573,866
- Ian Roger Bothwell$173,234
- Angad Mehta$1,709,070
Others in their field
Top investigators on “Antineoplastic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,409,738
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Gregory H Reaman · National Childhood Cancer Foundation$94,722,934
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Walter John Curran · Thomas Jefferson University$55,187,978
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
Research focus
Antineoplastic AgentsPharmaceutical PreparationsYeastsFluorescence-Activated Cell SortingGene LibraryEnzymesRibosomesSurfacePeptidesLibrariesPharmacologic SubstanceSmall MoleculeNatural ProductsBiologicalPathway InteractionsAntibioticsDiagnosisNext Generation SequencingGenome SequencingMutation AnalysisBaseNovel StrategiesEnzyme SubstrateFocus Groups
Grant awards (8)
High throughput biosynthesis of ribosomally synthesized and post-translationally modified peptide natural products$342,224
R35 · FY2025 · GM · contact PI
High throughput biosynthesis of ribosomally synthesized and post-translationally modified peptide natural products$342,605
R35 · FY2024 · GM · contact PI
High throughput biosynthesis of ribosomally synthesized and post-translationally modified peptide natural products$342,964
R35 · FY2023 · GM · contact PI
High throughput biosynthesis of ribosomally synthesized and post-translationally modified peptide natural products$343,303
R35 · FY2022 · GM · contact PI
High throughput biosynthesis of ribosomally synthesized and post-translationally modified peptide natural products$343,623
R35 · FY2021 · GM · contact PI
Targeting protein-protein interactions through directed evolution of lanthipeptid$58,002
F32 · FY2016 · GM · contact PI
Targeting protein-protein interactions through directed evolution of lanthipeptid$54,194
F32 · FY2015 · GM · contact PI
Targeting protein-protein interactions through directed evolution of lanthipeptid$51,530
F32 · FY2014 · GM · contact PI